Skip to main content
padlock icon - secure page this page is secure

Iodination and Stability of Somatostatin Analogues: Comparison of Iodination Techniques. A Practical Overview

Buy Article:

$68.00 + tax (Refund Policy)

For iodination (125/127I) of tyrosine-containing peptides, chloramin-T, Pre-Coated Iodo-GenĀ® tubes and Iodo- BeadsĀ® (Pierce) are commonly used for in vitro radioligand investigations and there have been reliant vendors hereof for decades. However, commercial availability of these radio-iodinated peptides is decreasing. For continuation of our research in this field we investigated and optimized (radio-)iodination of somatostatin analogues. In literature, radioiodination using here described somatostatin analogues and iodination techniques are described separately. Here we present an overview, including High Performance Liquid Chromatography (HPLC) separation and characterisation by mass spectrometry, to obtain mono- and di-iodinated analogues. Reaction kinetics of 125/127I iodinated somatostatin analogues were investigated as function of reaction time and concentration of reactants, including somatostatin analogues, iodine and oxidizing agent. To our knowledge, for the here described somatostatin analogues, no 127I iodination and optimization are described. (Radio-)iodinated somatostatin analogues could be preserved with a >90% radiochemical purity for 1 month after reversed phase HPLC-purification.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: 125I; 127I; chloramin-T; iodination; octreotide; radio-iodination; radiolysis; somatostatin; stability

Document Type: Research Article

Publication date: December 1, 2012

More about this publication?
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more